Related Experiment Video
Updated: Jun 19, 2026
14:37
High-throughput Synthesis of Carbohydrates and Functionalization of Polyanhydride Nanoparticles
Published on: July 6, 2012
11.4K
Synthetic hemozoin as a nanocarrier for cross-presentation
Letícia Torres-Dias1, Rebeca Santana Souza2, Jessica Carolina Alves Moreira2
1Post-Graduation Program in Health Science, Santo Amaro University (UNISA), São Paulo, Brazil.
Immunobiology
|August 1, 2024
Summary
Synthetic hemozoin (sHz) can act as a nanocarrier for antigens, potentially enhancing cross-presentation by dendritic cells. This finding highlights sHz
Area of Science:
- Immunology
- Cell Biology
- Nanotechnology
Background:
- Conventional antigen presentation involves MHC class II for CD4 T cells.
- Cross-presentation activates CD8 T cells via MHC class I using exogenous antigens.
- Dendritic cells (DCs) play a crucial role in cross-presentation, with receptors like CLEC9A involved.
Purpose of the Study:
- To investigate if synthetic hemozoin (sHz) or hematin anhydride can function as nanocarriers.
- To assess the potential of sHz to promote cross-presentation in dendritic cells.
Main Methods:
- Synthesis of hemozoin from hematin anhydride.
- Coupling and coating of antigens onto synthetic hemozoin.
- Analysis of antigen association with LAMP1-positive vesicles and intracellular pH changes in DCs.
Main Results:
- Verified that synthetic hemozoin can effectively carry coupled and coated antigens.
- Demonstrated that synthetic hemozoin associates with LAMP1-positive vesicles.
- Observed a decrease in intracellular pH, suggesting enhanced antigen processing for cross-presentation.
Conclusions:
- Synthetic hemozoin exhibits immunomodulatory properties.
- Synthetic hemozoin shows potential as an antigen carrier for enhancing cross-presentation.
- This study contributes to understanding the molecular mechanisms of antigen presentation.
Related Concept Videos
01:19Drug Absorption Mechanism: Carrier-Mediated Membrane Transport
Certain large, lipid-insoluble drug molecules that resemble amino acids, peptides, or glucose, require specialized carrier proteins to facilitate their diffusion across cell membranes. This transport can occur through either facilitated diffusion, which does not require energy input, or active transport, which does require energy input.
Facilitated diffusion is a passive process that utilizes human Solute Carrier (SLC) transporters. These transporters bind to the drug, undergo structural...
Facilitated diffusion is a passive process that utilizes human Solute Carrier (SLC) transporters. These transporters bind to the drug, undergo structural...
01:22Antigen Presenting Cells
The immune system is a complex network of cells and molecules that protects the body from foreign invaders. T cells, a type of white blood cell, play a crucial role in this process. They recognize and attack foreign substances, such as pathogens, that enter the body.
T cells require the help of antigen-presenting cells (APCs), which process foreign antigens into smaller fragments that can be recognized by T cells. These APCs are highly specialized cells that efficiently internalize antigens...
T cells require the help of antigen-presenting cells (APCs), which process foreign antigens into smaller fragments that can be recognized by T cells. These APCs are highly specialized cells that efficiently internalize antigens...
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...